CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Pauls Dietrich John President & CEO | Grant or award | +60,200 | 128,791 | ||
| 2026-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-06-01 | Pauls Dietrich John President & CEO | Grant or award · Stock Option (right to buy) | +380,000 | 380,000 | ||
| 2026-06-01 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +51,189 | 51,189 | ||
| 2026-06-01 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-06-01 | Krop Julie Chief Medical Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2026-06-01 | Kellen Scott CFO & Secretary | Grant or award · Stock Option (right to buy) | +162,000 | 162,000 | ||
| 2026-06-01 | Lewis Tanya Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-06-01 | O'Connor Daniel J. Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-06-01 | Kuntz Richard Director | Grant or award · Stock Option (right to buy) | +40,412 | 40,412 | ||
| 2026-01-02 | Semba Charles Pauling Director | Grant or award | +3,355 | $8.42 | $28K | 47,963 |
| 2026-01-02 | Parsons James T. Director | Grant or award | +10,095 | $8.42 | $85K | 97,949 |
| 2026-01-02 | Giuffre Randall Michael Director | Grant or award | +6,175 | $8.42 | $52K | 398,587 |
| 2025-11-25 | STAHLBERG JAN 10% owner | Purchase | +73,099 | $8.57 | $627K | 8,825,742 |
| 2025-11-24 | STAHLBERG JAN 10% owner | Purchase | +40,253 | $7.89 | $318K | 8,752,643 |
| 2025-11-21 | STAHLBERG JAN 10% owner | Purchase | +208,872 | $7.41 | $1.5M | 8,712,390 |
| 2025-11-21 | Parsons James T. Director | Option exercise | +12,000 | $2.20 | $26K | 87,854 |
| 2025-11-21 | Parsons James T. Director | Option exercise · Stock Option (right to buy) | −12,000 | 0 | ||
| 2025-11-20 | STAHLBERG JAN 10% owner | Purchase | +128,426 | $7.41 | $951K | 8,503,518 |
| 2025-11-19 | STAHLBERG JAN 10% owner | Purchase | +240,352 | $7.21 | $1.7M | 8,375,092 |
Page 1 of 10 · 189 trades